Global Patent Index - EP 1014983 A1

EP 1014983 A1 2000-07-05 - NAPROXEN/CETIRIZINE COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY DISORDERS

Title (en)

NAPROXEN/CETIRIZINE COMPOSITIONS AND METHODS FOR TREATING RESPIRATORY DISORDERS

Title (de)

NAPROXEN/CETIRIZIN ZUSAMMENSETZUNGEN UND VERFAHREN ZUR BEHANDLUNG VON ATEMWEGSERKRANKUNGEN

Title (fr)

COMPOSITIONS ET PROCEDES DE TRAITEMENT DE TROUBLES RESPIRATOIRES

Publication

EP 1014983 A1 (EN)

Application

EP 98938852 A

Priority

  • IB 9801339 W
  • US 93403397 A

Abstract (en)

[origin: WO9915173A1] The present invention relates to compositions and methods for providing improved treatment, management or mitigation of cold, cold-like, allergy, sinus and/or flu symptoms by administering a safe and effective amount of a composition comprising naproxen along with cetirizine.

IPC 1-7 (main, further and additional classification)

A61K 31/495

IPC 8 full level (invention and additional information)

A61K 31/445 (2006.01); A61K 31/192 (2006.01); A61K 31/495 (2006.01); A61P 11/02 (2006.01); A61P 11/14 (2006.01)

CPC (invention and additional information)

A61K 31/495 (2013.01)

Combination set (CPC)

  1. A61K 31/495 + A61K 31/19
  2. A61K 31/495 + A61K 2300/00

Citation (search report)

See references of WO 9915173A1

Designated contracting state (EPC)

AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

EPO simple patent family

WO 9915173 A1 19990401; AU 8744398 A 19990412; BR 9812660 A 20000822; CA 2304005 A1 19990401; CN 1278728 A 20010103; CO 5011084 A1 20010228; EP 1014983 A1 20000705; HU 0004813 A2 20010828; JP 2001517626 A 20011009; NO 20001412 D0 20000317; PE 118999 A1 20000203

INPADOC legal status


2002-07-03 [18D] DEEMED TO BE WITHDRAWN

- Effective date: 20020103

2001-10-10 [17Q] FIRST EXAMINATION REPORT

- Effective date: 20010823

2000-07-05 [17P] REQUEST FOR EXAMINATION FILED

- Effective date: 20000330

2000-07-05 [AK] DESIGNATED CONTRACTING STATES:

- Kind Code of Ref Document: A1

- Designated State(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE